2 reports

Its product portfolio includes prescription ophthalmic products, antirheumatics, OTC drugs, anti-allergy ophthalmic products, prescription anti-rheumatic drugs and medical devices such as intraocular lenses, among others.

  • Ophthalmology
  • Type 2 Diabetes
  • Company
  • Product Initiative
  • Allergan plc

In September 2014, National Institute of Allergy and Infectious Diseases in collaboration with Immune Tolerance Network (ITN) registered a Phase I/ II study of AMG-## to find out if cat allergy shots with combination with AMG- ##, an experimental medication, will help the cat

  • Blood Disease
  • Monoclonal Antibody
  • Therapy
  • Type 2 Diabetes
  • Amgen Inc.